Insulin and GLP-1

Joel introduces a novel approach to managing insulin sensitivity through a strategic diet that alternates between insulin-stimulating foods and GLP-1-boosting fats. Nathalie highlights the potential of GLP-1 agonists in treating not just diabetes and obesity, but also cognitive decline linked to Alzheimer's. The conversation delves into the fascinating connection between gut bacteria, specifically acromancia, and their role in enhancing GLP-1 levels, emphasizing the importance of gut health in overall metabolic efficiency.